Results 211 to 215 of about 21,696 (215)

The Effect of CYP3A4 Inhibition or Induction on the Pharmacokinetics and Pharmacodynamics of Orally Administered Ruxolitinib (INCB018424 Phosphate) in Healthy Volunteers

Journal of Clinical Pharmacology, 2012
Swamy Yeleswaram, William V Williams, Ryan F McGee   +2 more
exaly  

Tumoricidal effects of the JAK inhibitor Ruxolitinib (INC424) on hepatocellular carcinoma

Cancer Letters, 2013
Wei Duan, Liang Qiao, Lionel Hebbard
exaly  

Multiple administrations of fluconazole increase plasma exposure to ruxolitinib in healthy adult subjects

Cancer Chemotherapy and Pharmacology, 2019
Savita Bharathy
exaly  

Ruxolitinib: A Review in Polycythaemia Vera

Drugs, 2015
Kate McKeage
exaly  

Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial

Annals of Hematology, 2018
Jeannie Callum, Francesco Passamonti, Francesca Palandri   +2 more
exaly